Effect of Body Mass Index on the Survival Benefit of Liver Transplantation
Open Access
- 28 November 2007
- journal article
- research article
- Published by Wolters Kluwer Health in Liver Transplantation
- Vol. 13 (12) , 1678-1683
Abstract
Obese patients are at higher risk for morbidity and mortality after liver transplantation (LT) than nonobese recipients. However, there are no reports assessing the survival benefit of LT according to recipient body mass index (BMI). A retrospective cohort of liver transplant candidates who were initially wait-listed between September 2001 and December 2004 was identified in the Scientific Registry of Transplant Recipients database. Adjusted Cox regression models were fitted to assess the association between BMI and liver transplant survival benefit (posttransplantation vs. waiting list mortality). During the study period, 25,647 patients were placed on the waiting list. Of these, 4,488 (17%) underwent LT by December 31, 2004. At wait-listing and transplantation, similar proportions were morbidly obese (BMI ≥ 40; 3.8% vs. 3.4%, respectively) and underweight (BMI < 20; 4.5% vs. 4.0%, respectively). Underweight patients experienced a significantly higher covariate-adjusted risk of death on the waiting list (hazard ratio [HR] = 1.61; P < 0.0001) compared to normal weight candidates (BMI 20 to P = 0.15) compared to recipients of normal weight. In conclusion, compared to patients on the waiting list with a similar BMI, all subgroups of liver transplant recipients demonstrated a significant ( P < 0.0001) survival benefit, including morbidly obese and underweight recipients. Our results suggest that high or low recipient BMI should not be a contraindication for LT. Liver Transpl, 2007. © 2007 AASLD.Keywords
This publication has 16 references indexed in Scilit:
- AASLD practice guidelinesHepatology, 2005
- Thirty-day and one-year predictors of death in noncardiac major surgical proceduresThe American Journal of Surgery, 2004
- Cardiovascular morbidity and obesity in adult liver transplant recipientsTransplantation Proceedings, 2003
- Efficacy and Toxicity of a Protocol Using Sirolimus, Tacrolimus and Daclizumab in a Nonhuman Primate Renal Allotransplant ModelAmerican Journal of Transplantation, 2002
- Obesity and its effect on survival in patients undergoing orthotopic liver transplantation in the United StatesHepatology, 2002
- The Continuing Epidemics of Obesity and Diabetes in the United StatesJAMA, 2001
- Postoperative morbidity, mortality, costs, and long-term survival in severely obese patients undergoing orthotopic liver transplantationAmerican Journal of Gastroenterology, 2001
- The Spread of the Obesity Epidemic in the United States, 1991-1998JAMA, 1999
- Increased early morbidity and mortality with acceptable long‐term function in severely obese patients undergoing liver transplantationClinical Transplantation, 1999
- Liver transplantation in the morbidly obeseJournal of Clinical Anesthesia, 1996